中华骨质疏松和骨矿盐疾病杂志
中華骨質疏鬆和骨礦鹽疾病雜誌
중화골질소송화골광염질병잡지
CHINESE JOURNAL OF OSTEOPOROSIS AND BONE MINERAL RESEARCH
2014年
3期
221-226
,共6页
陈爽%张巧%时立新%彭年春%徐淑静%张淼%张松%周世菊
陳爽%張巧%時立新%彭年春%徐淑靜%張淼%張鬆%週世菊
진상%장교%시립신%팽년춘%서숙정%장묘%장송%주세국
代谢综合征%骨密度
代謝綜閤徵%骨密度
대사종합정%골밀도
metabolic syndrome%bone mineral density
目的:了解代谢综合征及其组分对骨密度的影响。方法2009年11月至2010年2月贵阳市居民健康横断面调查的1512名20~79岁调查对象(男性636名,女性876名)纳入本研究,受试者平均年龄(45.3±14.4)岁。对所有受试者进行问卷调查及体格检查,用OLYMPUS AU5400全自动生化分析仪检测空腹静脉血糖及餐后2 h血糖、三酰甘油、高密度脂蛋白胆固醇、血钙、血磷、血肌酐及血尿酸,用ROCHE 化学发光法测定血清胰岛素;用双能X线检测股骨颈、全髋、 Wards三角、粗隆及腰椎正位( L1-4)骨密度。结果完成血脂、尿酸、血糖、血钙、血磷、血肌酐、血胰岛素及骨密度检测者1216名,发现代谢综合征患者356例,患病率为29.3%,其中男性125例(35.1%),女性231例(64.9%);代谢综合征组骨折患病率为5.1%,非代谢综合征组为3.3%;代谢综合征患者全髋及粗隆骨密度较非代谢综合征者高[(0.95±0.15) g/cm2比(0.93±0.14) g/cm2;(0.76±0.13) g/cm2比(0.73±0.12) g/cm2;均P<0.01];校正性别及年龄后,股骨颈、全髋、 Wards三角、粗隆及L1-4骨密度值均随代谢综合征患者组份增加而增高(均P<0.01)。结论代谢综合征患者有较高的全髋及粗隆骨密度,但其骨折率亦较高。
目的:瞭解代謝綜閤徵及其組分對骨密度的影響。方法2009年11月至2010年2月貴暘市居民健康橫斷麵調查的1512名20~79歲調查對象(男性636名,女性876名)納入本研究,受試者平均年齡(45.3±14.4)歲。對所有受試者進行問捲調查及體格檢查,用OLYMPUS AU5400全自動生化分析儀檢測空腹靜脈血糖及餐後2 h血糖、三酰甘油、高密度脂蛋白膽固醇、血鈣、血燐、血肌酐及血尿痠,用ROCHE 化學髮光法測定血清胰島素;用雙能X線檢測股骨頸、全髖、 Wards三角、粗隆及腰椎正位( L1-4)骨密度。結果完成血脂、尿痠、血糖、血鈣、血燐、血肌酐、血胰島素及骨密度檢測者1216名,髮現代謝綜閤徵患者356例,患病率為29.3%,其中男性125例(35.1%),女性231例(64.9%);代謝綜閤徵組骨摺患病率為5.1%,非代謝綜閤徵組為3.3%;代謝綜閤徵患者全髖及粗隆骨密度較非代謝綜閤徵者高[(0.95±0.15) g/cm2比(0.93±0.14) g/cm2;(0.76±0.13) g/cm2比(0.73±0.12) g/cm2;均P<0.01];校正性彆及年齡後,股骨頸、全髖、 Wards三角、粗隆及L1-4骨密度值均隨代謝綜閤徵患者組份增加而增高(均P<0.01)。結論代謝綜閤徵患者有較高的全髖及粗隆骨密度,但其骨摺率亦較高。
목적:료해대사종합정급기조분대골밀도적영향。방법2009년11월지2010년2월귀양시거민건강횡단면조사적1512명20~79세조사대상(남성636명,녀성876명)납입본연구,수시자평균년령(45.3±14.4)세。대소유수시자진행문권조사급체격검사,용OLYMPUS AU5400전자동생화분석의검측공복정맥혈당급찬후2 h혈당、삼선감유、고밀도지단백담고순、혈개、혈린、혈기항급혈뇨산,용ROCHE 화학발광법측정혈청이도소;용쌍능X선검측고골경、전관、 Wards삼각、조륭급요추정위( L1-4)골밀도。결과완성혈지、뇨산、혈당、혈개、혈린、혈기항、혈이도소급골밀도검측자1216명,발현대사종합정환자356례,환병솔위29.3%,기중남성125례(35.1%),녀성231례(64.9%);대사종합정조골절환병솔위5.1%,비대사종합정조위3.3%;대사종합정환자전관급조륭골밀도교비대사종합정자고[(0.95±0.15) g/cm2비(0.93±0.14) g/cm2;(0.76±0.13) g/cm2비(0.73±0.12) g/cm2;균P<0.01];교정성별급년령후,고골경、전관、 Wards삼각、조륭급L1-4골밀도치균수대사종합정환자조빈증가이증고(균P<0.01)。결론대사종합정환자유교고적전관급조륭골밀도,단기골절솔역교고。
Objective The aim of the study is to assess the impact of metabolic syndrome ( MS) and its multi-component on bone mineral density (BMD).Methods We conducted a cross-sectional evaluation of 1512 participants in the general community from November 2009 to February 2010 Guiyang Health Measures Survey .The mean age was 45.3 ± 14.4years.All the subjects underwent questionnaire , anthropometric measurements , blood biochemical analyses .Fasting plasma glucose, 2-hour plasma glucose, serum triglycerides, high density lipoprotein cholesterol, insulin, calcium, phos-phorus , creatinine and uric acid were measured by automatic biochemical analyzer ( OLYMPUS AU5400 ) .Plasma insulin were measured by Chemiluminescence method (ROCHE).The BMD (g/cm2) of the femoral neck, Wards, trochanter, total hip and lumbar spine ( L1-4 ) were measured using a lunar prodigy scanner [ GE Medicail System ( China ) Co. Ltd].Results The prevalence of MS was 29.3% (356 person) of the complete data objectives (1 216 person), within 125 male (35.1%) and 231 female (64.9%), respectively.The prevalence of fracture in MS was higher than Non-MS slightly (5.1%in comparison with 3.3%). In comparison with Non-MS, all BMD values were higher in the MS groups , although only significantly different for total hip and femoral trochanter ( P<0.01 ) , After age and gender ad-justed, a gradual increase of mean levels BMD of all sits was seen when the components of MS was from one up to five ( P<0.01 ) .Conclusion Our study suggests that the MS group represented a higher BMD of total hip and femoral tro -chanter, while also indicated a higher fracture rate than Non-MS group.